Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belle Pharm
Shanghai, Shanghai, Chinabellepharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Belle Pharma is a clinical-stage biopharmaceutical company primarily focused on the development of innovative therapies for dermatological and autoimmune conditions. The company maintains a robust pipeline of small molecules and biologics targeting high-value mechanisms such as IL-17 and JAK pathways. Its lead programs are currently undergoing clinical evaluation for indications including plaque psoriasis and atopic dermatitis. Belle Pharma aims to address significant unmet medical needs in the global dermatology market through its specialized R&D capabilities based in China and the United States.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Biotech
Beyond the preview
Go deeper on Belle Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belle Pharm.